Latest Biocomposites News & Updates

See the latest news and media coverage for Biocomposites. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Biocomposites

Medical device company for musculoskeletal infection management

biocomposites.com
Headquarters
Keele, United Kingdom
Founded year
1997
Company type
Private company
Number of employees
350–500

Latest news about Biocomposites

In short: Biocomposites expanded its global footprint, secured major investment from Novo Holdings, and achieved key EU MDR certifications for its products.

Company announcements

  • Biocomposites

    Biocomposites launches SYNICEM bone cement in UK

    The company brings forward the launch to address NHS supply crisis, doubles production to one million packs yearly. SYNICEM products are CE marked with antibiotic options.

  • Biocomposites

    Biocomposites gains MDR certification for STIMULAN Rapid Cure and Kit

    STIMULAN is certified for mixing with vancomycin, gentamicin, tobramycin, and combinations to treat bone and soft tissue infections. It resolves infections and reduces secondary surgeries.

  • Biocomposites

    Biocomposites launches SYNICEM spacers in Canada

    The ready-to-use antibiotic-loaded preformed spacers for hip, knee, and shoulder revisions preserve space and treat infections. They offer various designs and geometries.

  • Biocomposites

    Biocomposites announces direct availability of products in Germany

    STIMULAN, genex, NanoBone, and SYNICEM Spacers are now offered directly. Dirk Schmitz leads sales as National Sales Manager.

Unlock all announcements with a

Media coverage

  • MSN

    Biocomposites gains EU MDR certification for antibiotics carrier

    Biocomposites' STIMULAN bone infection management products have gained certification under the European Union's Medical Device Regulation (EU MDR). The British medtech company's STIMULAN Rapid Cure...

  • Hospital Management

    Biocomposites to launch Synicem in UK for orthopaedic applications

    Biocomposites is set to launch its Synicem bone cement products in the UK with immediate effect for orthopaedic surgeries.

  • Markets Insider

    Biocomposites to launch SYNICEM™ bone cement in UK to ease supply crisis

    Biocomposites responds to NHS supply crisis by bringing forward launch of its SYNICEM™ bone cement products in the UKOver 500,000 SYNICEM™ bone...

  • MarketWatch

    Biocomposites gains MDR certification for STIMULAN(R) Rapid Cure and STIMULAN(R) Kit

    STIMULAN(R) certified to be mixed with a combination of Gram-positive and Gram-negative antibiotics STIMULAN(R) certified to resolve infection and reduce the need for secondary surgery...

Unlock all articles with a

Never miss news about Biocomposites

Track Biocomposites and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Biocomposites competitors & trending companies

Browse news for competitors to Biocomposites and other trending companies.